Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent
(OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
Important Differences between the Anti-Kickback Statute and Stark Law
Last Updated: 2023-03-04 Dr. Nick Oberheiden, Esq. healthcare-fraud-defense.com 888-680-1745 Including Weekends What works in other industries typically does not work in the healthcare industry. It is critical to understand that while it is more than common to pay for business on a quid-pro-quo basis in many other industries, healthcare laws...
Read more
When Does a Physician Joint Venture Arrangement Violate the Anti-Kickback Statute?
Oberheiden, P.C. www.healthcare-fraud-defense.com (214)-692-2171 Including Weekends It has become commonplace for healthcare providers to affiliate with ancillary services companies, often through an investment into laboratories, medical equipment suppliers, or physical therapy clinics. While such investments are not illegal, healthcare providers and healthcare businesses must ensure compliance with important laws that...
Read more
Defending Anti-Kickback Charges in DOL Pharmacy Investigations
Dr. Nick Oberheiden, Esq. www.healthcare-fraud-defense.com Direct: 888-680-1745 Including Weekends The attorneys of Oberheiden, P.C. have seen a tremendous increase in government investigations into pharmacies and compound pharmacies that service beneficiaries of the Department of Labor’s (DOL) healthcare program. The following is a brief summary of the government’s DOL anti-kickback and...
Read more
Medical Research Studies and Anti-Kickback Investigations
Federal investigators view pharmaceutical research studies with a suspicious eye to make sure that such studies are not merely a façade for medical marketing tactics. Such suspicion follows the exposure of numerous kickback schemes disguised as research studies, including schemes committed by major corporations. For example, pharmaceutical stalwart Merck &...
Read more
Defending Physicians against Kickback Charges in Connection with PGX Testing
Laboratory Kickback Prosecutions Since 2014, when the Department of Health and Human Services’ Office of the Inspector General released a Special Fraud Alert regarding improper payments by laboratories to referring physicians, federal investigators have increasingly focused on the relationships between laboratories and physicians. Federal investigators are particularly on the lookout...
Read more